Pharma Mar (Spain) Top Management
PHM Stock | EUR 75.50 0.10 0.13% |
Pharma Mar employs about 477 people. The company is managed by 10 executives with a total tenure of roughly 1113 years, averaging almost 111.0 years of service per executive, having 47.7 employees per reported executive. Evaluation of Pharma Mar's management performance can provide insight into the firm performance.
Pedro Puentes Insider Ex ViceChairman |
Jose SousaFaro Insider Ex Founder |
Pharma |
Pharma Mar Management Team Effectiveness
The company has return on total asset (ROA) of 0.1326 % which means that it generated a profit of $0.1326 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4705 %, meaning that it generated $0.4705 on every $100 dollars invested by stockholders. Pharma Mar's management efficiency ratios could be used to measure how well Pharma Mar manages its routine affairs as well as how well it operates its assets and liabilities.Pharma Mar Workforce Comparison
Pharma Mar SA is considered to be number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 4,668. Pharma Mar retains roughly 477 in number of employees claiming about 10% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.35 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.33 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.33. Pharma Mar SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharma Mar SA Price Series Summation is a cross summation of Pharma Mar price series and its benchmark/peer.
Pharma Mar Notable Stakeholders
A Pharma Mar stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pharma Mar often face trade-offs trying to please all of them. Pharma Mar's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pharma Mar's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Pedro Puentes | Ex ViceChairman | Profile | |
Jose SousaFaro | Ex Founder | Profile | |
Sandra Sanchez | Global Head | Profile | |
Elena Crespo | Director Admin | Profile | |
Jos MartinezLosa | Director Relations | Profile | |
Mara Caballero | Chief Officer | Profile | |
Juan Nogues | Director Sales | Profile | |
Juan Carretero | Founder | Profile | |
Lara Vadillo | Communication Director | Profile | |
Juan Pulido | Gen Directors | Profile |
About Pharma Mar Management Performance
The success or failure of an entity such as Pharma Mar SA often depends on how effective the management is. Pharma Mar management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain. PHARMA MAR operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 599 people.
Please note, the presentation of Pharma Mar's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pharma Mar's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pharma Mar's management manipulating its earnings.
Pharma Mar Workforce Analysis
Traditionally, organizations such as Pharma Mar use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pharma Mar within its industry.Pharma Mar Manpower Efficiency
Return on Pharma Mar Manpower
Revenue Per Employee | 481.8K | |
Revenue Per Executive | 23M | |
Net Income Per Employee | 194.7K | |
Net Income Per Executive | 9.3M |
Complementary Tools for Pharma Stock analysis
When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |